These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 20683565)
1. [Indications for parathyroidectomy in renal hyperparathyroidism: comments on the significance of new therapeutics]. Dotzenrath C Chirurg; 2010 Oct; 81(10):902-8. PubMed ID: 20683565 [TBL] [Abstract][Full Text] [Related]
2. Calcimimetics versus parathyroidectomy: What is preferable? Rroji M; Spasovski G Int Urol Nephrol; 2018 Jul; 50(7):1271-1275. PubMed ID: 29532306 [TBL] [Abstract][Full Text] [Related]
3. Parathyroidectomy in the Management of Secondary Hyperparathyroidism. Lau WL; Obi Y; Kalantar-Zadeh K Clin J Am Soc Nephrol; 2018 Jun; 13(6):952-961. PubMed ID: 29523679 [TBL] [Abstract][Full Text] [Related]
11. Decreasing Surgical Management of Secondary Hyperparathyroidism in the United States. Fligor SC; Li C; Hamaguchi R; William J; James BC J Surg Res; 2021 Aug; 264():444-453. PubMed ID: 33848844 [TBL] [Abstract][Full Text] [Related]
12. Impact of calcimimetics in surgery of secondary hyperparathyroidism. Ruiz J; Ríos A; Rodríguez JM; Llorente S; Hernández AM; Parrilla P Endocrinol Diabetes Nutr; 2017 Jan; 64(1):59-61. PubMed ID: 28440773 [No Abstract] [Full Text] [Related]
13. [Renal osteodystrophy (3); its treatment in dialysis patients]. Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385 [TBL] [Abstract][Full Text] [Related]
14. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan. Iseki K Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161 [TBL] [Abstract][Full Text] [Related]
15. Dysphoria induced in dialysis providers by secondary hyperparathyroidism. Soomro IH; Goldfarb DS Clin J Am Soc Nephrol; 2015 Jan; 10(1):9-11. PubMed ID: 25516914 [No Abstract] [Full Text] [Related]
16. The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial. Floege J; Kubo Y; Floege A; Chertow GM; Parfrey PS Clin J Am Soc Nephrol; 2015 May; 10(5):800-7. PubMed ID: 25887067 [TBL] [Abstract][Full Text] [Related]
17. [Definition of hyperparathyroidism and indication for surgical therapy]. Ziegler R Chirurg; 1999 Oct; 70(10):1077-81. PubMed ID: 10550336 [TBL] [Abstract][Full Text] [Related]
18. Changing landscape of the treatment of hyperparathyroidism related to end-stage renal disease-can we turn the clock backward? Kruijff S; van der Plas WY; Dulfer RR; Vriens MR; van Ginhoven TM; Engelsman AF; Delbridge LW Surgery; 2019 Feb; 165(2):289-290. PubMed ID: 30266441 [No Abstract] [Full Text] [Related]
19. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism. Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177 [TBL] [Abstract][Full Text] [Related]
20. Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review. van der Plas WY; Dulfer RR; Engelsman AF; Vogt L; de Borst MH; van Ginhoven TM; Kruijff S; Nephrol Dial Transplant; 2017 Nov; 32(11):1902-1908. PubMed ID: 28402557 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]